15 Comments
 

Thank you guys for inputting so far.

RC very strong for sure. Interested in hearing more about deal size, as far as I am aware RC v good for volume. IK CVP and PJT dominate biopharma mega deals in US. Interested in hearing about UK/Europe from a HC mega deal perspective too

 
Most Helpful

Quick overview of Europe: 

Evercore's pretty decent - they did AstraZeneca / Alexion + a few other deals, fair mix between sell and buy sides. 

CVP is good for biotech sell sides (in the US), they were also involved in AstraZeneca / Alexion + I think they're trying to replicate that franchise here in Europe. They've been involved in a sell sides here. 

Not sure why you mentioned PJT here - not sure what they do here in Europe. (AbbVie / Allergan doesn't count even though Allergan is "Irish") 

Rothschild and Jefferies are volume shops - predominately PE sell sides. Quick Linkedin search of their profiles and you'd realize they have relatively better PE exits than the aforementioned 3 shops 

From Mergermarket (excluding the BBs, Big4 and MM players, including the generally accepted "EBs" + Jefferies), Target / Acquirer: Europe, Date: 01/01/19 - 14/2/21 (sorted by deal size)

1. Evercore

2. PJT

3. CVP

4. Roths

5. Lazard

6. Jefferies

7. Moelis

Array
 

Wasn't EVR on the buy-side on those deals if I recall? i.e. less fees - how are they number 1?

I think this is very inaccurate...

CVP was on the sell-side of most the mega deals this year. One of their partners, Richard Girling (London partner) is a beast in HC . Also Rothschild and Laz did way better than EVR this year as well.

Dont know much about the rest so can't comment, but EVR as number 1 in London is a joke... Yes they're respected, did a lot better in 2019 than this year, but definitely not number one, they did poor from a fee perspective. 

 

Architecto aut totam eligendi nesciunt illo in sunt blanditiis. Ea neque quam temporibus illum. Optio dolore eos aut itaque similique illo. Eos libero temporibus consequatur neque. Consectetur quo ipsa alias non nisi. Ducimus eligendi voluptatem exercitationem ut qui voluptatem at.

Ut sit eius suscipit voluptate enim. Voluptatem alias sequi delectus illo perspiciatis sed quos.

Aut mollitia numquam voluptas quo. Ipsum exercitationem nulla et neque. Sunt itaque rerum maiores et vitae veniam quisquam. Voluptas fugiat alias ab.

Et exercitationem officia omnis. Facilis et saepe odit fuga et est voluptatem incidunt. Sed mollitia sit mollitia aut nobis. Non dolorem labore velit quo quia eaque. Et cupiditate omnis amet est quam. Accusantium id doloremque tempore et.

Career Advancement Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Morgan Stanley 08 97.8%
  • Goldman Sachs 02 97.3%

Overall Employee Satisfaction

August 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.4%
  • Banco Santander 02 97.8%
  • BMO Capital Markets 12 97.3%

Professional Growth Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.4%
  • Goldman Sachs 01 97.8%
  • JPMorgan 01 97.3%

Total Avg Compensation

August 2026 Investment Banking

  • Vice President (16) $429
  • Associates (48) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (25) $178
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (83) $151
  • Intern/Summer Analyst (75) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
kanon's picture
kanon
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
GameTheory's picture
GameTheory
98.9
6
Betsy Massar's picture
Betsy Massar
98.9
7
dosk17's picture
dosk17
98.9
8
DrApeman's picture
DrApeman
98.9
9
CompBanker's picture
CompBanker
98.9
10
Linda Abraham's picture
Linda Abraham
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”